• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing

3 'Wide Moat' Stocks That Could Float Your Boat

This trio enjoys competitive advantages that should serve investors well over the long haul.
By JOHN REESE
Dec 04, 2015 | 04:30 PM EST
Stocks quotes in this article: UN, ACN, GSK, WMT

Companies with competitive advantages tend to be high performers. They may be large and enjoy economies of scale, such as Wal-Mart (WMT), and can charge low prices while remaining profitable. Or, like pharmaceutical companies, they may have patents that protect their products and allow them to charge high prices.

Morningstar rates many companies based on what it calls an "economic moat," which "refers to how likely a company is to keep competitors at bay for an extended period." Among the variables considered for an economic moat are patents, brands, cost advantages, efficiency of scale, and switching costs, among others.

Recently, I looked at several companies Morningstar rates as enjoying the greatest economic moat advantage, which it calls a "wide moat." I found three that I, too, agree have competitive advantages. In addition, these three companies also earn a top recommendation from one of my guru strategies, which are automated strategies I created to mirror how some of history's greatest investors choose stocks to buy.

Consumer products giant Unilever (UN) is one of these companies. It has economies of scale, while owning lots of shelf space at retailers. With such brands as Dove, Hellmann's, Lipton, and Ben & Jerry's, this company enjoys the advantages that come from both scope and scale. My guru strategy based on the writings of James P. O'Shaughnessy is a strong supporter of Unilever because of the company's size ($132 billion market cap), positive cash flow per share, nearly 3 billion shares outstanding and huge sales ($54.5 billion). In addition, the stock pays a 2.99% dividend.

Accenture (ACN) is a giant consulting and IT services company with operations in more than 120 countries and more than 350,000 employees. Such factors as the cost to customers of switching from Accenture and its size give ACN a competitive advantage. My Warren Buffett-based strategy likes Accenture. It considers the company to have a competitive size advantage and dominant market position. Also in the company's favor -- earnings per share that have increased in eight of the past 10 years, almost no debt compared to earnings, a 49.0% return on equity over the past decade, and a projected 17.9% rate of return over the next 10 years for investors.

GlaxoSmithKline (GSK) is one of the world's major health care companies, with operations in more than 150 countries. Patents, size and financial resources all help give this company a competitive advantage. Like Unilever, GSK is a favorite of my O'Shaughnessy-based strategy because of its market cap ($101 billion), positive cash flow per share, large number of outstanding shares, and sizable sales ($35.6 billion). In addition, the stock has a 5.96% dividend yield.

Competitive advantages, strong financial performances, dominant market positions and well-priced stocks all contribute to making these companies worthy of buying today.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, John Reese and his clients were long UN, ACN, GSK and WMT.

TAGS: Investing | U.S. Equity

More from Investing

Chevron Is Not Only Greasing the Wheels, It's Turbocharging Them

Jim Collins
Jan 26, 2023 5:07 PM EST

Let's look at why CVX's buyback news is a big deal for investors.

Traders Hold Their Noses and Buy

James "Rev Shark" DePorre
Jan 26, 2023 4:27 PM EST

The dull market got a boost from Tesla, but this is not the kind of action we want to see.

Phillips 66 Looks Like It's on the Right Route

Bruce Kamich
Jan 26, 2023 1:33 PM EST

PSX appears poised for further gains as earnings approach, according to the charts and indicators.

In the Wild World of Crypto, a Wild Bitcoin Play Is the Best Call

Mark Abssy
Jan 26, 2023 1:24 PM EST

The situation for bitcoin investors right now is tough, but as we look at the crypto exchange-traded funds and the digital currency, I see one good 'option.'

The Long-Term Trend of Booz Allen Hamilton Is Bullish

Bruce Kamich
Jan 26, 2023 12:15 PM EST

If the earnings report is bearish, here's what to know.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 03:06 PM EST BOB LANG

    LEAPS Webinar

    This week, I offered a free webinar session talkin...
  • 02:53 PM EST REAL MONEY

    LIVE EVENT: Chris Versace and "Sarge" Guilfoyle Share Their Stock Market Insights

    This Monday, Jan. 30, at 12 p.m., our very own exp...
  • 04:58 PM EST REAL MONEY

    The Latest AAP Podcast!

    Listen in as AAP Tackles Earnings, the Fed, Recess...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login